BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32785916)

  • 1. [IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease].
    Reinshagen M
    Z Gastroenterol; 2020 Aug; 58(8):786. PubMed ID: 32785916
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease.
    Abadie V; Kim SM; Lejeune T; Palanski BA; Ernest JD; Tastet O; Voisine J; Discepolo V; Marietta EV; Hawash MBF; Ciszewski C; Bouziat R; Panigrahi K; Horwath I; Zurenski MA; Lawrence I; Dumaine A; Yotova V; Grenier JC; Murray JA; Khosla C; Barreiro LB; Jabri B
    Nature; 2020 Feb; 578(7796):600-604. PubMed ID: 32051586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new mouse model of coeliac disease with villous atrophy].
    Abadie V
    Med Sci (Paris); 2020 Nov; 36(11):969-972. PubMed ID: 33151855
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology: Context is key in the gut.
    Maynard CL; Weaver CT
    Nature; 2011 Mar; 471(7337):169-70. PubMed ID: 21390118
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens.
    DePaolo RW; Abadie V; Tang F; Fehlner-Peach H; Hall JA; Wang W; Marietta EV; Kasarda DD; Waldmann TA; Murray JA; Semrad C; Kupfer SS; Belkaid Y; Guandalini S; Jabri B
    Nature; 2011 Mar; 471(7337):220-4. PubMed ID: 21307853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease.
    Hovhannisyan Z; Weiss A; Martin A; Wiesner M; Tollefsen S; Yoshida K; Ciszewski C; Curran SA; Murray JA; David CS; Sollid LM; Koning F; Teyton L; Jabri B
    Nature; 2008 Nov; 456(7221):534-8. PubMed ID: 19037317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease.
    Lundin KE; Gjertsen HA; Scott H; Sollid LM; Thorsby E
    Hum Immunol; 1994 Sep; 41(1):24-7. PubMed ID: 7836060
    [No Abstract]   [Full Text] [Related]  

  • 8. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.
    Nilsen EM; Lundin KE; Krajci P; Scott H; Sollid LM; Brandtzaeg P
    Gut; 1995 Dec; 37(6):766-76. PubMed ID: 8537046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.
    Bodd M; Tollefsen S; Bergseng E; Lundin KE; Sollid LM
    Hum Immunol; 2012 Apr; 73(4):376-81. PubMed ID: 22342873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease].
    Nielsen C; Husby S; Lillevang ST
    Ugeskr Laeger; 2003 Feb; 165(9):917-20. PubMed ID: 12661516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gluten-sensitive coeliac disease and prevention of autoimmune diseases and tumors].
    Parfenov AI; Sabel'nikova EA; Krus LM; Gudkova RB
    Ter Arkh; 2007; 79(2):5-11. PubMed ID: 17460959
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent insight in the pathophysiology of coeliac disease: relevance to rheumatoid arthritis.
    Koning F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S8-10. PubMed ID: 26457726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathomechanisms in celiac disease.
    Dieterich W; Esslinger B; Schuppan D
    Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice.
    Black KE; Murray JA; David CS
    J Immunol; 2002 Nov; 169(10):5595-600. PubMed ID: 12421937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
    Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
    Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M; Kim CY; Lundin KE; Sollid LM
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of celiac disease.
    Koning F
    J Mol Recognit; 2003; 16(5):333-6. PubMed ID: 14523946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coeliac disease: it takes three to tango!
    Van De Wal Y; Kooy Y; Van Veelen P; Vader W; Koning F; Peña S
    Gut; 2000 May; 46(5):734-7. PubMed ID: 10764722
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance-inducing therapies in coeliac disease - mechanisms, progress and future directions.
    Sollid LM
    Nat Rev Gastroenterol Hepatol; 2024 May; 21(5):335-347. PubMed ID: 38336920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.